Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,061 to 2,080 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall. | Pathobiology | 2019 | 30396184 | PubTator, text mining | PubMed |
| Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP. | Oncogene | 2019 | 30390072 | PubTator, text mining | PubMed |
| Apoptosis: A biomarker of high-risk phenotype in pediatric acute myeloid leukemia? | Int J Lab Hematol | 2019 | 30383325 | PubTator, text mining | PubMed |
| Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO. | Leuk Lymphoma | 2019 | 30328750 | PubTator, text mining | PubMed |
| Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-κB pathway. | FASEB J | 2019 | 30307764 | PubTator, text mining | PubMed |
| Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident. | Am J Hematol | 2019 | 30295334 | PubTator, text mining | PubMed |
| Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients. | Leuk Lymphoma | 2019 | 30277115 | PubTator, text mining | PubMed |
| Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations. | J Mol Diagn | 2019 | 30273780 | PubTator, text mining | PubMed |
| The immunophenotypic characteristics and flow cytometric scoring system of acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1. | Int J Lab Hematol | 2019 | 30264491 | PubTator, text mining | PubMed |
| Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study. | Ann Hematol | 2019 | 30251205 | PubTator, text mining | PubMed |
| Clinical implications of molecular markers in acute myeloid leukemia. | Eur J Haematol | 2019 | 30203623 | PubTator, text mining | PubMed |
| Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing. | Haematologica | 2019 | 30190345 | PubTator, text mining | PubMed |
| Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia. | Haematologica | 2019 | 30171026 | PubTator, text mining | PubMed |
| Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion. | Oncogene | 2019 | 30093631 | PubTator, text mining | PubMed |
| A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia. | Haematologica | 2019 | 30093399 | PubTator, text mining | PubMed |
| MYC protein expression is an important prognostic factor in acute myeloid leukemia. | Leuk Lymphoma | 2019 | 29741984 | PubTator, text mining | PubMed |
| Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients. | Cancer Res Treat | 2019 | 29690749 | PubTator, text mining | PubMed |
| Structural modification of oridonin via DAST induced rearrangement. | RSC Adv | 2018 | 35547324 | PubTator, text mining | PubMed |
| Development and application of a rapid molecular method for detection of fusion genes in pediatric leukemia. | Int J Clin Exp Pathol | 2018 | 31938203 | PubTator, text mining | PubMed |
| BRAF Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition. | JCO Precis Oncol | 2018 | 31799491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=104